A committee called the Select Subcommittee has been charged by Congress with thoroughly investigating the COVID-19 pandemic, including the development of vaccines and the subsequent policies and mandates.
Must Watch: Would you live on 3D Printed Mars for a year for $60,000?
Members of Congress are getting ready to look into COVID-19 vaccine development and other vaccination-related issues.
Members of Congress have stated that the Select Subcommittee on the Coronavirus Pandemic intends to look into the regulatory procedure for regulating and approving the vaccines as well as why the vaccines were required.
Rep. Mariannette Miller-Meeks (R-Iowa) stated that one objective of the committee is to ensure that the United States is ready for upcoming pandemics, “and that includes perfecting our vaccine development”. “In order to do so, we must have complete transparency in vaccine research, clinical trials and adverse reactions, and manufacturing.”
“I expect our oversight hearings will shed light on the FDA approval process, the potential for side effects, and ultimately the success rate and safety of the vaccine—each of which will help us to navigate future global health emergencies,” she added.
Subscribe to GreatGameIndia
The group “will be performing a comprehensive review of how the vaccines were developed, approved, and mandated,” according to another member, Rep. Rich McCormick (R-Ga.).
Doctor McCormick is worried about how information on potential side effects has been gathered. In addition, he wants to investigate why primary series and at least one booster have been recommended for kids as young as 6 months old “given the lack of scientific evidence for a benefit, coupled with real concerns about possible harm for an otherwise immune person.”
When it comes to COVID-19, children are the least at risk. Based on immunogenicity evidence, or antibody generation, vaccines were approved for children for the prevention of symptomatic COVID-19. Data from the real world demonstrates that vaccinations offer momentary defense against symptomatic illness. Children and other people who have recovered from COVID-19 benefit from being protected against the illness, particularly against severe sickness, and some study has revealed that people have a higher risk of vaccine side effects following recovery.
“People do deserve to know about the long-term safety and efficacy of the vaccine. A lot of the things that were told to us, like ‘they prevent transmission’ and all of that, were not true. So people will have concerns and those concerns should be addressed,” said Rep. Nicole Malliotakis (R-N.Y.), another member of the subcommittee.
Rep. Debbie Lesko (R-Ariz.) pointed out that during the pandemic, the Centers for Disease Control and Prevention (CDC), which decides whether to recommend vaccines and the U.S. Food and Drug Administration (FDA), which approves vaccines, increasingly bypassed their expert advisory panels after the panels resisted decisions like advocating for boosters before a full analysis of trial data. In 2021, two senior FDA officials left their positions, one of whom desired additional time to review evidence on Pfizer’s vaccine.
“We need to know who made the decision to bypass the standard vaccine approval processes,” Lesko, a subcommittee member, told via email.
Lesko added that she also expects the panel would look at the motivations behind mandates’ imposition as well as their results.
“The COVID-19 vaccine mandates were a clear abuse of government authority, and we need to know who made the formal decision to implement these mandates. Additionally, I believe we need answers on the data from the COVID-19 clinical trials, given the significant disparity between the trials and real-world effects from these vaccines,” Lesko said. “I hope we can get to the bottom of these issues, and I am proud to work with my colleagues to get the long-overdue answers the American people deserve.”
The subcommittee was created by the House of Representatives in its set of rules.
The panel was given the green light to look into the causes of the COVID-19 pandemic, including the funding of risky experiments known as gain-of-function research by the American government, the use of taxpayer money and relief programs, including reports of fraud, and “the development of vaccines and treatments, and the development and implementation of vaccination policies for Federal employees and members of the armed forces.”
The package also allowed the panel to investigate the pandemic’s economic effects, Executive Branch communications and policies, and the societal effects of the decision to close schools across the nation.
In the previous Congress, a House select panel under Democratic leadership met. This panel looked at the Paycheck Protection Program (pdf below), the vaccine maker Emergent BioSolutions, and the Trump administration’s attempts to sway public health organizations.
According to Malliotakis, the Republican members of the new panel recently convened to discuss the priorities of the subcommittee. Investigating if the virus was created in the U.S.-funded lab in Wuhan, China, is one of them. Malliotakis also wants to look into Andrew Cuomo’s order to nursing home operators to accept patients even if they tested positive for COVID-19, which detractors claim caused needless deaths of elderly people.
Republicans in the last Congress raised many of the issues, but because they were the minority, they frequently did not get responses.
“We were ignored because we were in the minority and we didn’t have subpoena power to bring those people before us to testify. That’s the real difference here. Now, we have subpoena power,” Malliotakis said. “And so we’re going to respectfully ask again for the answers to our questions. If they don’t provide them, then the chairman may be forced to subpoena.”
Working under the House Oversight Committee is the coronavirus subcommittee. The panel’s chairman, Rep. James Comer (R-Ky.), declined to comment on whether witnesses who refuse to cooperate freely will be subpoenaed.
“The Select Subcommittee is charged with a thorough review of the pandemic, including the development of vaccines and the subsequent policies and mandates. Select Subcommittee Chairman Wenstrup is the right guy to lead the charge and I look forward to working with him,” Comer told via email. Rep. Brad Wenstrup (R-Ohio) is chairing the subcommittee.
Based on page 14 of the EMA’s August 2021 report, Pfizer’s report to the EMA made it clear that it knowingly allowed dangerous components in its vaccines.
The previous head of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, and other individuals who could provide light on the origins of COVID-19 were sought out for testimony as the new committee’s first official move.
The subcommittee was given the authority to release interim findings as it sees fit, but it was required to release a final report by Jan. 2, 2025.
Read the report given below: